Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ADD2 |
| Upstream (Parents) |
|---|
| (<<) U2AF2 → ADD2 |
| (<<) SLC22A4 → ADD2 |
| (<<) GSTT2 → ADD2 |
| (<<) ITGB6 → ADD2 |
| (<<) GAL3ST1 → ADD2 |
| (<<) TIAM1 → ADD2 |
| (<<) BDH2 → ADD2 |
| (<<) MEIS3P1 → ADD2 |
| (<<) C19orf57 → ADD2 |
| (<<) CCR2 → ADD2 |
| Downstream (Children) |
|---|
| ADD2 → DOCK6 (>>) |
| ADD2 → RPE65 (>>) |
| ADD2 → LIN28A (>>) |
